A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Sichuan Enray Pharmaceutical Sciences Company
University of Florida
Incyte Corporation
Yuhan Corporation
Marengo Therapeutics, Inc.
SCG Cell Therapy Pte. Ltd.